Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- TEMPOIndependent statistical analysis of Time Restricted Eating for Metabolic and Psychological Optimization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05997316).
- TEMPO-2Independent statistical analysis of A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2: Complete Statistical AnalysisIndependent statistical analysis of Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07339072).
- Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis: Complete Statistical AnalysisIndependent statistical analysis of Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00432835).
- Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC): Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020305).
- TEMSOIndependent statistical analysis of Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TendrilMRI™Independent statistical analysis of Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing Indication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TENEREIndependent statistical analysis of A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TENS and Opioid Use After Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of TENS and Opioid Use After Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03843788).
- Tension Versus Tension- Free Foley Balloon for Cervical Ripening: Complete Statistical AnalysisIndependent statistical analysis of Tension Versus Tension- Free Foley Balloon for Cervical Ripening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05404776).
- TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds: Complete Statistical AnalysisIndependent statistical analysis of TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TEPARFIndependent statistical analysis of PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TePOPIndependent statistical analysis of Telehealth Group Intervention for Perinatal Depressive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03932760).
- Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05213481).
- Tepotinib Hepatic Impairment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Hepatic Impairment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03546608).
- Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT): Complete Statistical AnalysisIndependent statistical analysis of Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833664).
- Terbinafine HCl 250 mg Tablet Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833586).
- TERIKIDSIndependent statistical analysis of Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia: Complete Statistical AnalysisIndependent statistical analysis of Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00623974).
- TESIndependent statistical analysis of Electric Stimulation of the Eye to Improve Vision After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02019927).
- TESIndependent statistical analysis of The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TESmTBIIndependent statistical analysis of Transcranial Electrical Stimulation for mTBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03244475).
- TESSERACTIndependent statistical analysis of Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574038).
- TESSERACT-BAIndependent statistical analysis of Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Test catheterIndependent statistical analysis of Test Catheter Pilot Study in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00832078).
- Testing a Digital Intervention for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Testing a Digital Intervention for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04567888).
- Testing a Neurocognitive Model of Distancing Using Transcranial Magnetic Stimulation.: Complete Statistical AnalysisIndependent statistical analysis of Testing a Neurocognitive Model of Distancing Using Transcranial Magnetic Stimulation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03698591).
- Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer:…
- Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women: Complete Statistical AnalysisIndependent statistical analysis of Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03558828).
- Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use: Complete Statistical AnalysisIndependent statistical analysis of Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body: Complete Statistical AnalysisIndependent statistical analysis of Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body: primary endpoint results, effect estimate…
- Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): Complete Statistical AnalysisIndependent statistical analysis of Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): Complete Statistical AnalysisIndependent statistical analysis of Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G): Complete Statistical AnalysisIndependent statistical analysis of Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Doxazosin to Treat Stress Mechanisms in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Testing Doxazosin to Treat Stress Mechanisms in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02989493).
- Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: Complete Statistical AnalysisIndependent statistical analysis of Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Testing Financial Incentive Interventions in Dyadic-Smoker Couples: Complete Statistical AnalysisIndependent statistical analysis of Testing Financial Incentive Interventions in Dyadic-Smoker Couples: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04832360).
- TEsting for Arterial Disease in Diabetes (TrEAD) Study: Complete Statistical AnalysisIndependent statistical analysis of TEsting for Arterial Disease in Diabetes (TrEAD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058626).